We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$546M
AUM Growth
+$20.5M
Cap. Flow
+$5.52M
Cap. Flow %
1.01%
Top 10 Hldgs %
55.37%
Holding
35
New
6
Increased
12
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$27.4M
2
BAX icon
Baxter International
BAX
+$16.4M
3
CNC icon
Centene
CNC
+$9.56M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.49M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$7.43M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$16.7M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$15M
3
BSX icon
Boston Scientific
BSX
+$11.7M
4
GILD icon
Gilead Sciences
GILD
+$10.3M
5
LH icon
Labcorp
LH
+$6.15M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
26
BioMarin Pharmaceuticals
BMRN
$11.6B
$6.92M 1.27%
+91,714
New +$7.49M
BNTX icon
27
BioNTech
BNTX
$23B
$5.9M 1.08%
+54,000
New +$5.73M
HCA icon
28
HCA Healthcare
HCA
$86.4B
$5.59M 1.02%
29,690
-34,520
-54% -$6.09M
RIGL icon
29
Rigel Pharmaceuticals
RIGL
$692M
$5.23M 0.96%
153,049
-6,816
-4% -$270K
JNJ icon
30
Johnson & Johnson
JNJ
$641B
$4.93M 0.9%
30,000
-5,000
-14% -$809K
UHS icon
31
Universal Health Services
UHS
$9.64B
$2.93M 0.54%
+21,994
New +$2.92M
REGN icon
32
Regeneron Pharmaceuticals
REGN
$69.9B
$2.31M 0.42%
+4,876
New +$2.37M
CVAC
33
DELISTED
CureVac
CVAC
$2.29M 0.42%
+25,000
New +$2.43M
ABT icon
34
Abbott
ABT
$182B
– –
-152,640
Closed -$16.7M
NVAX icon
35
Novavax
NVAX
$1.23B
– –
-11,500
Closed -$1.28M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2021 Portfolio in Review

As of Q1 2021, Sector Gamma AS held 35 positions worth $546M, up 3.9% from $525M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Sector Gamma AS's Q1 2021 filing shows 6 new, 12 increased, 15 reduced and 2 closed positions. Its largest new stake was Baxter International: 206,951 shares worth $17.5M. The largest sale was Abbott, an estimated $16.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q1 2021 buy was Baxter International: 206,951 shares worth $17.5M.
  • Sector Gamma AS added most to Pfizer in Q1 2021, an estimated $27.4M increase.
  • Sector Gamma AS's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $15M.
  • Sector Gamma AS fully exited Abbott in Q1 2021, selling an estimated $16.7M.
  • Sector Gamma AS's ten largest holdings make up 55% of its $546M portfolio in Q1 2021.
  • Sector Gamma AS opened 6 new positions and closed 2 in Q1 2021.
  • Sector Gamma AS's portfolio value rose 3.9% quarter-over-quarter to $546M.

Based on Sector Gamma AS's 13F filing for Q1 2021, filed 10 May 2021.